It’s not exactly a market secret that advisors and investors alike have been looking at value strategies in a new light as 2026 has progressed. Key Takeaways: Growth stocks have dominated the market narrative for years,…
With the Fed poised to meet this week to discuss rates at a critical economic moment, investors may want to prepare. Active ETFs offer the kind of seasoned management and flexibility that can adjust. Using the tradable,…
Nomura Asset Management, the largest ETF provider in Japan, is making a major push to establish its U.S. presence. Following the acquisition of Macquarie Asset Management’s U.S. public investments business in December 2…
After a strong spring and promising early summer, July saw homebuying stagnate as a result of rising borrowing costs, forcing sellers to slash prices to revive demand.
After the chaos of a software-led sell-off that bled into techs stocks at large and dragged the broader market, here are a few strategies from Wall Street pros that might help you navigate the next meltdown.
In late October, VettaFi hosted an interactive virtual event featuring market leaders from State Street Investment Management, Janus Henderson, and Horizon. During the presentation, advisor sentiment polls revealed a de…
For a while now, the story in bonds has been “higher for longer”, a reality underscored as the benchmark 10-year Treasury yield holds firm near 5.0%. The government keeps issuing debt at a rapid pace, inflation hasn’t f…
Poland’s first nuclear power plant is not expected to deliver electricity until 2036, but supply chain work has already begun. Earlier this month, state-owned Polskie Elektrownie Jądrowe (PEJ) commissioned Westinghouse …
Anthropic made its public debut on Wall Street’s calendar today. The company behind Claude filed a public IPO prospectus with the U.S. Securities and Exchange Commission on October 26, 2026, according to Reuters and The…
This week could mark something that hasn’t happened to me in years—I may end up selling my shares of AbbVie (ABBV) at a price below the market value. It’s all going to depend on if the share price ends the week above $2…
By Christopher Gannatti, CFA, Global Head of Research Key Takeaways Quantum computing progress is emerging across hardware, error-correction software and applications, with distinct evidence required at each layer. Conf…
The S&P 500 has been a reliable index for building exposure to U.S. stocks for years, and for good reason. It’s a valuable barometer for investors who want to make sure they are tracking large-cap U.S. equities. Key Tak…
The yield on the 10-year note finished October 23, 2026 at 5.00% while the 2-year note ended at 4.69%. The chart below overlays the daily performance of several Treasury bonds, starting from the pre-recession equity mar…
Could the near to medium term finally see value ETFs take the starring role back from growth? Value indices have provided some steady returns this year, but the question is, can they accelerate into the new year? Econom…
Prices are rising, but investors continue to pay for retirement. Investors young and old have looked to income ETFs as solutions. Historically, bond funds provided the yield and income investors desired; options-based i…
Whenever a new fund comes on to the market, it’s often interesting to see how the fund performs in its first few months. Key Takeaways: Despite launching a little over four months ago, the Guggenheim Ultra Short Income …
Third-quarter earnings season is in full bloom. With real estate investment trusts (REITs) soon stepping into the earnings spotlight, advisors and investors may want to evaluate ETFs such as the ALPS Active REIT ETF (RE…
Centrus Energy (LEU) recently acquired Westerman Holdings, securing a crucial manufacturing supplier as nuclear fuel demand accelerates. Westerman produces specialized equipment across several sectors, including nuclear…
October is typically a volatile month for stocks, with three market panics of historical significance occurring in 1929, 1987, and 2008. Fast forward to today’s volatility, U.S. equity markets are serving investors a sh…
VettaFi has been recognized as the Best U.S. Index Overall Provider at the ETF Express U.S. ETF Awards 2026, building on a standout year of index innovation, strategic acquisitions, and product milestone growth across t…
Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy. A GLP-1 pill from the …
Broadly speaking, when the average investor thinks about the term “artificial intelligence,” the first thing that comes to mind is usually digital, such as a chatbot or large language model (LLM). Key Takeaways: Physica…
Recent tensions in the Middle East and the resulting energy supply shock have heightened investor concerns about a return of stagflation—a period of rising inflation alongside slowing economic growth. While stagflation …